Skip to Main Content

Author Details

Christopher D Willey
University of Alabama at Birmingham
2000
96
27
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37449861Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain Metastases.Neurosurgery2023
37681903Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.Cells2023
37449861Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain Metastases.Neurosurgery2023
37323483Using 3D-bioprinted models to study pediatric neural crest-derived tumors.Int J Bioprint2023
37681903Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.Cells2023
37323483Using 3D-bioprinted models to study pediatric neural crest-derived tumors.Int J Bioprint2023
35195258Understanding Drug Sensitivity and Tackling Resistance in Cancer.Cancer Res2022
36008408Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.Nat Commun2022
35427545Patience Is a Virtue.Int J Radiat Oncol Biol Phys2022
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
35272839Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).J Pediatr Surg2022
35195258Understanding Drug Sensitivity and Tackling Resistance in Cancer.Cancer Res2022
35168148Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer.Neoplasia2022
35159029Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.Cancers (Basel)2022
35080075Factors associated with loss to follow-up after radiation therapy for head and neck cancer.Head Neck2022
35052809Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma.Biomedicines2022
35427545Patience Is a Virtue.Int J Radiat Oncol Biol Phys2022
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
36008408Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.Nat Commun2022
35159029Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy.Cancers (Basel)2022
35272839Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).J Pediatr Surg2022
35052809Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma.Biomedicines2022
35168148Inhibition of DNA-PK may improve response to neoadjuvant chemoradiotherapy in rectal cancer.Neoplasia2022
35080075Factors associated with loss to follow-up after radiation therapy for head and neck cancer.Head Neck2022
30888548Cancer Explant Models.Curr Top Microbiol Immunol2021
32350670Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer.Support Care Cancer2021
33632630Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance Results.Pract Radiat Oncol2021
33727604PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.Sci Rep2021
34206917Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.Cancers (Basel)2021
33720050N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.J Clin Invest2021
33658160Predictors of In-Hospital Death in Patients with Lung Cancer Admitted for Acute Radiation Pneumonitis: A Healthcare Cost and Utilization Project (HCUP) Analysis.Clin Lung Cancer2021
34870191Corrigendum: Statistical Enrichment Analysis of Samples: A General-Purpose Tool to Annotate Metadata Neighborhoods of Biological Samples.Front Big Data2021
34604741Statistical Enrichment Analysis of Samples: A General-Purpose Tool to Annotate Metadata Neighborhoods of Biological Samples.Front Big Data2021
30888548Cancer Explant Models.Curr Top Microbiol Immunol2021
33720050N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.J Clin Invest2021
33727604PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.Sci Rep2021
33632630Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance Results.Pract Radiat Oncol2021
33658160Predictors of In-Hospital Death in Patients with Lung Cancer Admitted for Acute Radiation Pneumonitis: A Healthcare Cost and Utilization Project (HCUP) Analysis.Clin Lung Cancer2021
34870191Corrigendum: Statistical Enrichment Analysis of Samples: A General-Purpose Tool to Annotate Metadata Neighborhoods of Biological Samples.Front Big Data2021
34604741Statistical Enrichment Analysis of Samples: A General-Purpose Tool to Annotate Metadata Neighborhoods of Biological Samples.Front Big Data2021
34206917Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.Cancers (Basel)2021
32350670Lipid microsphere bound oxycodone for pain management in patients receiving radiotherapy for head and neck cancer.Support Care Cancer2021
32231273Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.Oncogene2020
32069320Novel EGFR ectodomain mutations associated with ligand-independent activation and cetuximab resistance in head and neck cancer.PLoS One2020
32231273Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.Oncogene2020
33665483Control and Toxicity in Melanoma Versus Other Brain Metastases in Response to Combined Radiosurgery and PD-(L)1 Immune Checkpoint Inhibition.Adv Radiat Oncol2020
33095971Surface guided imaging during stereotactic radiosurgery with automated delivery.J Appl Clin Med Phys2020
32523959Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.Kidney Dis (Basel)2020
33133138Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth.Front Genet2020
33077834A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.Oncogene2020
  • 1 - 50 of 192

Recommended Authors

Daniel J McGrail
Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic
Career Start Year 2012
Number of shared co-authors 1
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Career Start Year 2011
Number of shared co-authors 0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 3
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Robert Cornelison
University of Virginia
Career Start Year 2000
Number of shared co-authors 1
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Nhu-An Pham
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1998
Number of shared co-authors 0
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Career Start Year 1996
Number of shared co-authors 1
Peter S Hammerman
Novartis Institutes for BioMedical Research
Career Start Year 1996
Number of shared co-authors 1
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 1
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 0
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 1
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 3
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 0
Aykut Uren
Georgetown University Medical Center
Career Start Year 1991
Number of shared co-authors 1
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 0
Lori S Hart
Children's Hospital of Philadelphia, USA. [2] Center for Childhood Cancer Research
Career Start Year 1987
Number of shared co-authors 0
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 0
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 8
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Joshua C Anderson
University of Alabama at Birmingham
Co-authored papers 38
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Co-authored papers 18
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Co-authored papers 13
Anita B Hjelmeland
University of Alabama at Birmingham
Co-authored papers 7
Nicholas Eustace
City of Hope National Medical Center
Co-authored papers 6
Zongliang Yue
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers 4
Catherine P Langford
University of Alabama at Birmingham
Co-authored papers 4
Jake Y. Chen (CM4AI)
University of Alabama at Birmingham
Co-authored papers 4
Jake Y Chen
Co-authored papers 4
David K Crossman
University of Alabama at Birmingham
Co-authored papers 3
Thanh Nguyen
University of Alabama at Birmingham
Co-authored papers 3
William E Grizzle
University of Alabama at Birmingham
Co-authored papers 3
Dongquan Chen
University of Alabama at Birmingham
Co-authored papers 3
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Co-authored papers 2
Chuan Xing
The University of Alabama at Birmingham, Hazelrig Salter Radiation Oncology Center
Co-authored papers 2
Jonas S Almeida
National Cancer Institute (NCI)
Co-authored papers 2
Ali G Gharavi
Columbia University College of Physicians and Surgeons
Co-authored papers 2
Krzysztof Kiryluk
Columbia University
Co-authored papers 2
Smita Bhatia
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham
Co-authored papers 2
Samuel Bharti
Amity Institute of Biotechnology, Amity University
Co-authored papers 1
Samuel Bharti
Amity Institute of Biotechnology, Amity University
Co-authored papers 1
Fady M Mikhail
University of Alabama at Birmingham
Co-authored papers 1
Xianwei Cui
Nanjing Medical University
Co-authored papers 1
Christian T Stackhouse
Co-authored papers 1
Paul A Goepfert
Co-authored papers 1
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 1
Dong Wook Kim
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 1
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Co-authored papers 1
Jessy S Deshane
Co-authored papers 1
Michael S Saag
University of Alabama at Birmingham
Co-authored papers 1
Release 1.2